What Caused The Exicure (XCUR) Stock To Rise After-Hours On Monday?
Following the early-stage biotechnology company’s announcement of the cancellation of an agreement, shares of Exicure Inc. (NASDAQ: XCUR) were up 81.68% to trade at $1.2901 in after-hours at the last check. Which contract has XCUR left? Exicure (XCUR) announced the cancellation of its collaboration agreements with Ipsen BioPharm Limited and AbbVie, Inc. (Ipsen). Exicure was […]
Blistering updated pushed Exicure, Inc. (XCUR), stock downwards in the premarket
Exicure, Inc. (Nasdaq: XCUR), plunged -9.52% to $1.9 in the premarket session after a pharmaceutical leader in novel biopharmaceuticals incorporating spherical nucleic acids, today announced that U.S. Patent and Trademark Office has issued two new patents, No.10,792,251 (the ‘251 patent) and No. 10,837,018 (the ‘018 patent), and allowed U.S. patent application 14/907,430 (the ‘430 application), […]